SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

CARE revises ratings of Ahlcon Parenterals’ bank facilities

26 Feb 2014 Evaluate

Credit rating agency, CARE has revised rating of Ahlcon Parenterals’ long term bank facilities worth Rs 16.91 crore which was reduced from Rs 21.19 crore to ‘A’ from ‘BBB+’. The rating agency has also revised rating of company’s Long-term/Short-term bank facilities worth Rs 9.00 crore to ‘A/ A1’ from ‘BBB+/A2’.

The revision in the ratings of the bank facilities of Ahlcon Parenterals (APIL) takes into account the improvement in its financial profile as reflected by the increase in its profitability margins and improvement in leverage ratios. 

Ahlcon Parenterals (India) manufactures pharmaceutical intravenous (I.V.) fluids, medical disposables, and opthalmics/ear drops. It offers I.V. fluids, antimicrobial I.V. fluids, plasma volume expanders in BFS bottles, and nasal drops.

Peers
Company Name CMP
Sun Pharma Inds. 1619.95
Dr. Reddys Lab 1315.85
Cipla 1294.75
Zydus Lifesciences 927.15
Lupin 2296.10
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×